199 related articles for article (PubMed ID: 18625767)
1. Heterocyclic compounds that inhibit Rev-RRE function and human immunodeficiency virus type 1 replication.
Shuck-Lee D; Chen FF; Willard R; Raman S; Ptak R; Hammarskjold ML; Rekosh D
Antimicrob Agents Chemother; 2008 Sep; 52(9):3169-79. PubMed ID: 18625767
[TBL] [Abstract][Full Text] [Related]
2. Transduction of human CD34+ hematopoietic progenitor cells by a retroviral vector expressing an RRE decoy inhibits human immunodeficiency virus type 1 replication in myelomonocytic cells produced in long-term culture.
Bahner I; Kearns K; Hao QL; Smogorzewska EM; Kohn DB
J Virol; 1996 Jul; 70(7):4352-60. PubMed ID: 8676458
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the Rev-RRE interaction by aromatic heterocyclic compounds.
Zapp ML; Young DW; Kumar A; Singh R; Boykin DW; Wilson WD; Green MR
Bioorg Med Chem; 1997 Jun; 5(6):1149-55. PubMed ID: 9222509
[TBL] [Abstract][Full Text] [Related]
4. Proflavine acts as a Rev inhibitor by targeting the high-affinity Rev binding site of the Rev responsive element of HIV-1.
DeJong ES; Chang CE; Gilson MK; Marino JP
Biochemistry; 2003 Jul; 42(26):8035-46. PubMed ID: 12834355
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of HIV-1 replication by targeting the Rev protein.
Nakaya T; Iwai S; Fujinaga K; Otsuka E; Ikuta K
Leukemia; 1997 Apr; 11 Suppl 3():134-7. PubMed ID: 9209321
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain.
Lee SW; Gallardo HF; Gilboa E; Smith C
J Virol; 1994 Dec; 68(12):8254-64. PubMed ID: 7966618
[TBL] [Abstract][Full Text] [Related]
7. Identification of benzenesulfonamide quinoline derivatives as potent HIV-1 replication inhibitors targeting Rev protein.
Zhong F; Geng G; Chen B; Pan T; Li Q; Zhang H; Bai C
Org Biomol Chem; 2015 Feb; 13(6):1792-9. PubMed ID: 25503645
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of HIV-1 Rev-RRE interaction by diphenylfuran derivatives.
Ratmeyer L; Zapp ML; Green MR; Vinayak R; Kumar A; Boykin DW; Wilson WD
Biochemistry; 1996 Oct; 35(42):13689-96. PubMed ID: 8885849
[TBL] [Abstract][Full Text] [Related]
9. 1'S-1'-acetoxychavicol acetate isolated from Alpinia galanga inhibits human immunodeficiency virus type 1 replication by blocking Rev transport.
Ye Y; Li B
J Gen Virol; 2006 Jul; 87(Pt 7):2047-2053. PubMed ID: 16760408
[TBL] [Abstract][Full Text] [Related]
10. Evolution of the HIV-1 Rev Response Element during Natural Infection Reveals Nucleotide Changes That Correlate with Altered Structure and Increased Activity over Time.
Sherpa C; Jackson PEH; Gray LR; Anastos K; Le Grice SFJ; Hammarskjold ML; Rekosh D
J Virol; 2019 Jun; 93(11):. PubMed ID: 30867301
[TBL] [Abstract][Full Text] [Related]
11. Continuous propagation of RRE(-) and Rev(-)RRE(-) human immunodeficiency virus type 1 molecular clones containing a cis-acting element of simian retrovirus type 1 in human peripheral blood lymphocytes.
Zolotukhin AS; Valentin A; Pavlakis GN; Felber BK
J Virol; 1994 Dec; 68(12):7944-52. PubMed ID: 7966585
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the HIV-1 rev-RRE complex formation by unfused aromatic cations.
Xiao G; Kumar A; Li K; Rigl CT; Bajic M; Davis TM; Boykin DW; Wilson WD
Bioorg Med Chem; 2001 May; 9(5):1097-113. PubMed ID: 11377168
[TBL] [Abstract][Full Text] [Related]
13. Defective lentiviral vectors are efficiently trafficked by HIV-1 and inhibit its replication.
Klimatcheva E; Planelles V; Day SL; Fulreader F; Renda MJ; Rosenblatt J
Mol Ther; 2001 Jun; 3(6):928-39. PubMed ID: 11407907
[TBL] [Abstract][Full Text] [Related]
14. Nuclear Factor 90, a cellular dsRNA binding protein inhibits the HIV Rev-export function.
Urcuqui-Inchima S; Castaño ME; Hernandez-Verdun D; St-Laurent G; Kumar A
Retrovirology; 2006 Nov; 3():83. PubMed ID: 17125513
[TBL] [Abstract][Full Text] [Related]
15. The rev-responsive element negatively regulates human immunodeficiency virus type 1 env mRNA expression in primate cells.
Churchill MJ; Moore JL; Rosenberg M; Brighty DW
J Virol; 1996 Sep; 70(9):5786-90. PubMed ID: 8709194
[TBL] [Abstract][Full Text] [Related]
16. An alpha-helical peptidomimetic inhibitor of the HIV-1 Rev-RRE interaction.
Mills NL; Daugherty MD; Frankel AD; Guy RK
J Am Chem Soc; 2006 Mar; 128(11):3496-7. PubMed ID: 16536504
[TBL] [Abstract][Full Text] [Related]
17. A DEAD box protein facilitates HIV-1 replication as a cellular co-factor of Rev.
Fang J; Kubota S; Yang B; Zhou N; Zhang H; Godbout R; Pomerantz RJ
Virology; 2004 Dec; 330(2):471-80. PubMed ID: 15567440
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of HIV replication by sense and antisense rev response elements in HIV-based retroviral vectors.
Kim JH; McLinden RJ; Mosca JD; Vahey MT; Greene WC; Redfield RR
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Aug; 12(4):343-51. PubMed ID: 8673542
[TBL] [Abstract][Full Text] [Related]
19. Rev/RRE-independent Mason-Pfizer monkey virus constitutive transport element-dependent propagation of SIVmac239 vectors using a single round of replication assay.
Rizvi TA; Schmidt RD; Lew KA; Keeling ME
Virology; 1996 Aug; 222(2):457-63. PubMed ID: 8806531
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
